NCT04751929 2026-02-20Abemaciclib With or Without Atezolizumab for mCRPCDana-Farber Cancer InstitutePhase 2 Active not recruiting19 enrolled 13 charts
NCT05288166 2025-06-27CYCLONE 3Eli Lilly and CompanyPhase 3 Active not recruiting925 enrolled 12 charts
NCT03706365 2025-04-20CYCLONE 2Eli Lilly and CompanyPhase 2/3 Active not recruiting393 enrolled 23 charts